DiaMedica Therapeutics, Inc. (DMAC)
DiaMedica Therapeutics Market Cap : 442.66M for Feb. 19, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| XOMA Royalty Corp. | 302.15M |
| Avantor, Inc. | 6.282B |
| ACADIA Pharmaceuticals, Inc. | 4.116B |
| Alnylam Pharmaceuticals, Inc. | 45.01B |
| Savara, Inc. | 1.164B |
Market Cap Related Metrics
| PEG Ratio | -0.3985 |
| Price to Book Value | 8.575 |
| Price | 8.50 |
| Earnings Yield | -8.44% |
| PEGY Ratio | -0.3985 |